Baseline characteristics of 1622 male patients of the Alpha Omega Trial who were included in the study on PSA change, by treatment group*.

Data are reported as mean ± standard deviation (SD) or percentages (%).ALA = alpha linolenic acid, EPA = eicosapentanoic acid = EPA, DHA = docosahexanoic acid.*Subjects with initial PSA concentrations >4 ng/mL (n = 255) were excluded, see Methods and Figure 1.**Body mass index ≥30 kg/m2.†Self-reported diabetes diagnosed by a physician and/or treatment with antidiabetic medication and/or elevated plasma glucose level.‡High school at intermediate or higher level, or higher vocational education college or university.